Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparing Treatments for Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 32

Registration Number: NCT00001750

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Completed

Conditions: Leiomyomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 400

Registration Number: NCT00001869

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Electromechanical Mapping to Evaluate Heart Muscle

Phase 3

Completed

Conditions: Myocardial Ischemia

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 71

Registration Number: NCT00001895

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Medical Treatment for Diamond Blackfan Anemia

Phase 2

Completed

Conditions: Fanconi's Anemia
Hematologic Disease

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 25

Registration Number: NCT00001749

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease

Completed

Conditions: Healthy
Hypertrophic Cardiomyopathy
Left Ventricular Hypertrophy

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 195

Registration Number: NCT00001632

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts

Completed

Conditions: Hypertrophic Cardiomyopathy
Left Ventricular Hypertrophy

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 175

Registration Number: NCT00001878

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Stem Cell Factor Medication for Aplastic Anemia

Phase 1

Completed

Conditions: Aplastic Anemia
Pancytopenia

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 40

Registration Number: NCT00001398

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Treatment of Pulmonary Sarcoidosis With Pentoxifylline

Phase 2

Completed

Conditions: Pulmonary Sarcoidosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 100

Registration Number: NCT00001877

Locations: 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Role of Genetic Factors in the Development of Lung Disease

Recruiting

Conditions: Pulmonary Fibrosis
Cystic Fibrosis
Tuberous Sclerosis
Pulmonary Sarcoidosis
Asthma

First Posted Date: 1999-11-04

Last Posted Date: 2025-06-10

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 3500

Registration Number: NCT00001532

Locations: 🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Phase 2

Completed

Conditions: Graft vs Host Disease
Leukemia
Chronic Lymphocytic Leukemia
Myelodysplastic Syndrome
Myeloid Leukemia

First Posted Date: 1999-11-04

Last Posted Date: 2019-12-17

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 28

Registration Number: NCT00001637

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy